⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | HDFC Flexi Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | HDFC MF | HDFC MF |
| Category | Equity - Flexi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹2,187.57 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Amit Ganatra | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -4.80% | 22.64% |
| 3Y | 15.72% | 30.41% |
| 5Y | 15.45% | — |
| Since Inception | 15.51% | 29.15% |
| Risk | ||
| 12.33 | 14.07 | |
| 0.85 | 0.59 | |
| 0.65 | 1.59 | |
| 4.75 | 21.67 | |
| 1.22 | 3.48 | |
| -12.32% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.77% | 1.03% |
| Exit Load | 1% on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
HDFC MF92%
HDFC MF92%
8.4%Only 8.4% of holdings by weight are common between HDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingHDFC MFHDFC MF
TREPS - Tri-party Repo2.81%4.67%
Cipla Ltd.2.47%4.15%
Divi's Laboratories Ltd.1.62%9.39%
Max Healthcare Institute Ltd.1.46%3.61%
Category context: Equity vs Equity. Open the full Screener →